[1]
Raoof, J., Hooper, D., Moore, A., Zaiac, M., Sullivan, T., Kircik, L., Lain, E., Jankivevic, J. and Stuart, I. 2018. FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Efficacy and Safety From a Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S56. DOI:https://doi.org/10.25251/skin.2.supp.56.